New Zealand’s market dragged its feet today because the long-awaiting earnings season is just days away and investors aren’t keen to make any big moves until the listed companies’ earnings results are in.

Investors stuck to the sidelines on Friday but look to be in better heart ahead of earnings season, with volumes showing some signs of life and the S&P/NZX 50 index adding 2% over the week.

Briscoe Group’s optimism about the second half of the year brought investors through the doors while A2 Milk continued to benefit from speculation it's about to get a green light to send baby formula to the United States.

Investors continued to hone in on A2 Milk today after last night's flurry of speculation over its access to the US, while weaker jobs data had some analysts predict a slower pace of rate hikes, increasing the allure of companies offering reliable dividends

A2 Milk pushed the S&P/NZX 50 Index into positive territory in a late trading surge on speculation the milk marketing firm might get access to the US.

Pacific Edge shares sank by almost 50% on the possibility its cancer tests will no longer be covered by a major US health insurance company after the cancer diagnostic company’s trading halt was lifted as the market opened today.

Mainfreight’s announcement yesterday that its US revenue increase of 41.4% to US$257.5 million ($408m) meant the logistic company’s stock rallied for a second day in the New Zealand share market (NZX).

Mainfreight shares jumped today after the logistics company highlighted its success in the United States to shareholders at its annual meeting.

Carbon Fund units jumped after the Climate Change Commission urged the government to tighten the emissions trading scheme.

Energy stocks all declined in New Zealand’s moody market today as investors wait to see what companies reveal to shareholders in the looming earnings season.

New Zealand's benchmark share index declined on Monday as investors became concerned about growing recession risks facing the global economy.

Cancer diagnostic company Pacific Edge's shares ended the week on a bright note as it continued its high-riding streak of recent days.

Pacific Edge led the New Zealand sharemarket higher for a second day on news the southern district health region would adopt its cancer test.

Pacific Edge led New Zealand's sharemarket higher on Wednesday after it reported volume numbers for its cancer test increased 32% on the same quarter last year.

New Zealand’s benchmark equity index remained unchanged on Tuesday in a second day of light trading, with many market participants away during school holidays.

New Zealand's benchmark share index moved higher on Monday, despite inflation data showing prices had risen more in the June quarter than many had expected.